iThriveMD review

iThriveMD combines a clinic network with online weight and longevity care. Its semaglutide and tirzepatide product cards explicitly describe 28-day charges for the one-cycle plan, an introductory discount and a higher standing rate. Longer offers are paid up front for 12, 24 or 48 weeks; the label “12-month” therefore does not mean 365 days of treatment. With a charge at enrollment and every 28 days afterward, there are 14 payment dates within the first 365 days, with the last covering time beyond that year. This cash-payment count is different from annualizing the recurring rate. The compounded semaglutide cost guide explains those units. The current shipping and some product-billing disclosures do not establish a consistent all-in total.

The main GLP-1 product pages include clinical oversight and coaching and say every dose has the same price. Their steps describe an online intake, consultation with diagnostic-laboratory review, treatment in clinic or at home if eligible, and continuing reassessment. Those descriptions do not establish that every laboratory charge is included. The current telehealth page advertises free two-day shipping, while the separate shipping policy lists a standard delivery charge and ground service. That policy also contains unfinished descriptions of subscription deliveries, delays and restrictions. Confirm the actual dispensing pharmacy, shipping charge, delivery window and what happens after a delayed or temperature-exposed shipment. A general delivery banner cannot resolve the terms of your prescription. Use the billing checklist to record the selected offer before paying.

The care team is more clearly identified than the dispensing pharmacy. The telehealth page names founder Samir Damani as a physician and cardiovascular specialist alongside eleven people described as naturopathic doctors. Its California licensing language is a provider statement, not an independent check of the person assigned to your care. Current site disclosures additionally identify Vishal Verma, Empower Aesthetics Medical Group and iThriveMD PC as possible doctors or facilities, and disclose financial interests or service relationships. Ask which entity is treating you, the prescriber’s professional license type, and how follow-up will work for your location. The telehealth page specifically promotes California care; listings also include Arizona, with Scottsdale described as a telehealth appointment. Confirm Arizona and product eligibility directly rather than assuming every location offers the same service.

The cancellation information is more specific than the short returns page suggests, but the documents still conflict. General terms section 14 allows cancellation through an account or by contacting the company, effective at the end of the current billing period, and says subscriptions are nonrefundable. The returns page says all purchases are final with no returns. Yet general terms section 15 describes returns of unused items for refund, credit or exchange, with missing numbers in its return and processing deadlines. Do not treat that generic merchandise language as a promise that prescription medicine can be returned. Obtain the product-specific rule, cancellation cutoff, effect on prepaid shipments and any medical-denial refund exception in writing. The advertised no-long-term-commitment one-cycle plan is different from recovering money already paid for a longer term.

The additional product menu requires its own questions. The metformin page says billed and shipped monthly with regular laboratory monitoring included, but the site-wide footer says all memberships charge every 28 days. That conflict prevents treating the inherited monthly figure as a confirmed comparable rate. Metformin for healthy aging is off-label; a longevity sales page does not establish prevention of cancer, dementia or aging. The separate microdosing tirzepatide page advertises prepaid plans and monthly visits, but its dose descriptions conflict internally. The prescriber and pharmacist must reconcile the contradictory schedule and exact preparation before providing administration instructions. Lower-dose branding, testimonials and claims of fewer side effects do not establish comparative safety or effectiveness. The microdose evidence guide and metformin evidence review address those distinct questions. Before comparing the provider lineup, request the pharmacy’s name and a written care and payment plan.